[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 410
Citations 0
Comment & Response
September 6, 2016

Methylphenidate for Attention-Deficit/Hyperactivity Disorder—Reply

Author Affiliations
  • 1Psychiatric Research Unit, Region Zealand, Denmark
  • 2Copenhagen Trial Unit, Copenhagen, Denmark
JAMA. 2016;316(9):995. doi:10.1001/jama.2016.10300

In Reply Dr Romanos and colleagues suggest that we included 5 trials in our Cochrane review1 that should have been excluded. We disagree. The 4 trials they state used active controls actually used these cointerventions similarly in both groups (ie, the methylphenidate and the control groups). Such trials should be included according to our protocol.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×